Connect with us

Business

Pfizer Says FDA Will Soon Authorize COVID-19 Vaccine For 12-15 Age Group – NPR

The company said in late March that clinical trials showed the vaccine elicits “100% efficacy and robust antibody responses” in adolescents.

Published

on

Article feature image
ADVERTISEMENT

Syringes filled with the Pfizer-BioNTech COVID-19 vaccine are shown in April at the Christine E. Lynn Rehabilitation Center in Miami.
Wilfredo Lee/AP
The U.S. Food and Drug Administration is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children 12 to 15 years old, a decision that could come by some time early next week. The vaccine is currently authorized only for people age 16 and older.
A ruling should come “shortly,” Pfizer Chairman and CEO Albert Bourla told investors in a…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Why trouble may loom for stock market if Cathie Wood’s ARK Innovation ETF fails to bounce – MarketWatch
Article feature image
House panel advances bipartisan retirement savings bill | TheHill – The Hill
Article feature image
Hard-hit restaurants rush for a lifeline as $28 billion in grants go up for grabs – CNBC